Compare ETON & WEAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | WEAV |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 411.9M | 487.7M |
| IPO Year | 2018 | 2021 |
| Metric | ETON | WEAV |
|---|---|---|
| Price | $17.61 | $5.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $31.00 | $11.00 |
| AVG Volume (30 Days) | 293.3K | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 13.04 |
| EPS | ★ N/A | N/A |
| Revenue | $39,011,000.00 | ★ $204,314,000.00 |
| Revenue This Year | $107.23 | $17.29 |
| Revenue Next Year | $29.72 | $13.46 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 23.29 | 19.85 |
| 52 Week Low | $11.09 | $4.85 |
| 52 Week High | $23.00 | $12.31 |
| Indicator | ETON | WEAV |
|---|---|---|
| Relative Strength Index (RSI) | 57.35 | 39.41 |
| Support Level | $17.38 | N/A |
| Resistance Level | $20.35 | $7.31 |
| Average True Range (ATR) | 1.06 | 0.36 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 41.19 | 35.63 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.